SMUP-IV-01

N/A

Report date: 2025/01/26 16:02:36

Base Information

Drug NameSMUP-IV-01

Drug Alias Nameallogeneic umbilical cord blood-derived mesenchymal stem cell therapy (Medipost)SMUP-IV-01

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Stem cell therapy > Umbilical cord stem cell therapy

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsDiabetic NephropathiesRespiratory Distress Syndrome, Adult

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesMedipost Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesMedipost Co Ltd

Inactive CompaniesN/A

Active IndicationsDiabetic NephropathiesRespiratory Distress Syndrome, Adult

Inactive IndicationsN/A

Other Information

ATC CodeN/A